Related Experiment Video
Updated: Oct 9, 2025

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Acute Infectious Gastroenteritis: The Causative Agents, Omics-Based Detection of Antigens and Novel Biomarkers
Haziqah Hasan1, Nor Ashika Nasirudeen1, Muhammad Alif Farhan Ruzlan1
1Department of Pediatric, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
Insights
Acute infectious gastroenteritis (AGE) in children is a major global health concern. Omics technologies offer new ways to find biomarkers for diagnosing and managing AGE, improving patient outcomes and infection control.
Area of Science:
- Infectious Diseases
- Molecular Diagnostics
- Public Health
Background:
- Acute infectious gastroenteritis (AGE) is a primary cause of mortality in children globally.
- Historically rotavirus, norovirus is now a leading viral cause, alongside bacterial and parasitic agents.
- Accurate diagnosis relies on identifying specific biological markers like antigens or genes.
Purpose of the Study:
- To review current biomarkers and antigens for diagnosing AGE pathogens.
- To explore the role of omics technologies in advancing AGE diagnosis and management.
- To highlight the potential of omics for discovering novel biomarkers and improving clinical workflows.
Main Methods:
- Literature review of current diagnostic markers for AGE.
- Exploration of omics technologies (genomics, proteomics, etc.) in pathogen identification.
- Analysis of the potential clinical applications of omics-derived insights.
Main Results:
- Various viral, bacterial, and parasitic agents cause AGE, each with specific markers.
- Omics technologies provide molecular-level insights into AGE pathogenesis and diagnosis.
- Multi-omics approaches, though costly, facilitate novel biomarker discovery.
Conclusions:
- Omics technologies are crucial for discovering new biomarkers for AGE management.
- Future applications include predicting prognosis, virulence, and drug susceptibility.
- Integrating omics into clinical workflows can enhance infection control, outbreak detection, and antimicrobial stewardship.
Abstract:
Acute infectious gastroenteritis (AGE) is among the leading causes of mortality in children less than 5 years of age worldwide. There are many causative agents that lead to this infection, with rotavirus being the commonest pathogen in the past decade. However, this trend is now being progressively replaced by another agent, which is the norovirus. Apart from the viruses, bacteria such as Salmonella and Escherichia coli and parasites such as Entamoeba histolytica also contribute to AGE. These agents can be recognised by their respective biological markers, which are mainly the specific antigens or genes to determine the causative pathogen. In conjunction to that, omics technologies are currently providing crucial insights into the diagnosis of acute infectious gastroenteritis at the molecular level. Recent advancement in omics technologies could be an important tool to further elucidate the potential causative agents for AGE. This review will explore the current available biomarkers and antigens available for the diagnosis and management of the different causative agents of AGE. Despite the high-priced multi-omics approaches, the idea for utilization of these technologies is to allow more robust discovery of novel antigens and biomarkers related to management AGE, which eventually can be developed using easier and cheaper detection methods for future clinical setting. Thus, prediction of prognosis, virulence and drug susceptibility for active infections can be obtained. Case management, risk prediction for hospital-acquired infections, outbreak detection, and antimicrobial accountability are aimed for further improvement by integrating these capabilities into a new clinical workflow.
More Related Videos
09:04Foodborne Pathogen Screening Using Magneto-fluorescent Nanosensor: Rapid Detection of E. Coli O157:H7
Published on: September 17, 2017
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021